Filing Flows

Filing Flows › CG Oncology (CGON) › How it makes money

How CG Oncology (CGON) makes money

CG Oncology (CGON) made $1.6M of revenue in the third quarter 2026 (Q3 2026), -4% from a year earlier.

Drawing the Sankey…

CG Oncology: revenue by line, Q3 2025 to Q2 2026CG Oncology: revenue by line, Q3 2025 to Q2 2026Commercial and Develo…License and Collabora…Commercial and Development Revenue: $1.1M latest$1.1MLicense and Collaboration Revenue: $10K latestQ3 2025Q4 2025Q1 2026Q2 2026
License and Collaboration Revenue went from 9% of revenue in Q3 2025 to 1% in Q2 2026, the largest shift in the mix.
CG Oncology revenue by quarterCG Oncology revenue by quarter$456KQ4 2024$52KQ1 2025$1.7MQ3 2025$2.3MQ4 2025$1.1MQ1 2026$1.2MQ2 2026$1.6MQ3 2026

Where each dollar of revenue goes

LineQ3 2026% of revenue
Revenue$1.6M100.0%

Revenue, quarter by quarter

QuarterRevenueY/Y
Q3 2026$1.6M-4%
Q2 2026$1.2M—
Q1 2026$1.1M21×
Q4 2025$2.3M+409%
Q3 2025$1.7M39×
Q1 2025$52K-90%
Q4 2024$456K456×

From CG Oncology's 10-Q filed Nov 6, 2026 (on EDGAR).

Questions

How does CG Oncology make money?

CG Oncology (CGON) made $1.6M of revenue in the third quarter 2026 (Q3 2026), -4% from a year earlier.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.